A Gary Lyons

Affiliations

  • Director at Neurocrine Biosciences Inc (NBIX), 2025-05-22
  • at Travere Therapeutics Inc. (TVTX), 2025-05-16
  • at Rigel Pharmaceuticals Inc (RIGL), 2023-07-12
  • Director at Eledon Pharmaceuticals Inc. (ELDN), 2023-05-02
  • Director at Brickell Biotech Inc. (BBI), 2022-05-17
  • Director at Cytori Therapeutics Inc. (CTYX), 2018-02-09
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2015-07-14
  • Director at Neurogesx Inc (NGSX), 2012-06-12
  • Director at Poniard Pharmaceuticals Inc. (PARD), 2011-07-12
  • Director at Facet Biotech Corp (FACT), 2010-04-23
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VICL $4.39 7,078 $31,088.70 14,906 2016-06-03 Filing
VICL $0.01 5,953 $59.53 63,281 2013-05-23 Filing
VICL $0.01 7,328 $73.28 57,328 2012-05-24 Filing
VICL $0.01 18,750 $187.50 50,000 2011-05-26 Filing
VICL $0.01 18,750 $187.50 31,250 2010-05-25 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TVTX $15.15 18,821 $285,226.61 51,000 2024-10-04 Filing
TVTX $14.35 21,179 $303,874.17 69,821 2024-10-04 Filing
NBIX $150.43 11,570 $1,740,449.65 119,047 2024-08-13 Filing
NBIX $150.03 930 $139,530.23 119,047 2024-07-16 Filing
NBIX $135.63 12,500 $1,695,370.00 116,947 2024-05-14 Filing